BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 34957746)

  • 1. [Long-term macrolide therapy in asthma].
    Paçacı Çetin G; Arslan B; Yılmaz İ
    Tuberk Toraks; 2021 Dec; 69(4):520-534. PubMed ID: 34957746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Azithromycin is the answer in paediatric respiratory medicine, but what was the question?
    Bush A
    Paediatr Respir Rev; 2020 Apr; 34():67-74. PubMed ID: 31629643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Azithromycin to prevent asthma exacerbations: only for patients with non-eosinophilic asthma].
    Braunstahl GJ
    Ned Tijdschr Geneeskd; 2020 May; 164():. PubMed ID: 32749816
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Macrolides and airway inflammation in children.
    Shinkai M; Rubin BK
    Paediatr Respir Rev; 2005 Sep; 6(3):227-35. PubMed ID: 16153572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial.
    Brusselle GG; Vanderstichele C; Jordens P; Deman R; Slabbynck H; Ringoet V; Verleden G; Demedts IK; Verhamme K; Delporte A; Demeyere B; Claeys G; Boelens J; Padalko E; Verschakelen J; Van Maele G; Deschepper E; Joos GF
    Thorax; 2013 Apr; 68(4):322-9. PubMed ID: 23291349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-inflammatory effects of macrolides--an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
    Amsden GW
    J Antimicrob Chemother; 2005 Jan; 55(1):10-21. PubMed ID: 15590715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of long term antibiotics in chronic respiratory diseases.
    Suresh Babu K; Kastelik J; Morjaria JB
    Respir Med; 2013 Jun; 107(6):800-15. PubMed ID: 23522403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of macrolide therapy in chronic obstructive pulmonary disease.
    Martinez FJ; Curtis JL; Albert R
    Int J Chron Obstruct Pulmon Dis; 2008; 3(3):331-50. PubMed ID: 18990961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Past, present and future of macrolide therapy for chronic rhinosinusitis in Japan.
    Shimizu T; Suzaki H
    Auris Nasus Larynx; 2016 Apr; 43(2):131-6. PubMed ID: 26441370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of azithromycin on asthma exacerbations and quality of life in adults with persistent uncontrolled asthma (AMAZES): a randomised, double-blind, placebo-controlled trial.
    Gibson PG; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Marks GB; Baraket M; Powell H; Taylor SL; Leong LEX; Rogers GB; Simpson JL
    Lancet; 2017 Aug; 390(10095):659-668. PubMed ID: 28687413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [LONG TERM TREATMENT WITH MACROLIDES IN CHRONIC LUNG DISEASES].
    Shteinberg M; Schneer S; Lavon O; Adir Y
    Harefuah; 2016 Sep; 155(9):567-571. PubMed ID: 28530085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Azithromycin or erythromycin? Macrolides for non-cystic fibrosis bronchiectasis in adults: A systematic review and adjusted indirect treatment comparison.
    Li W; Qin Z; Gao J; Jiang Z; Chai Y; Guan L; Chen Y
    Chron Respir Dis; 2019; 16():1479972318790269. PubMed ID: 30101613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for macrolide therapy of asthma and COPD.
    Parnham MJ; Norris V; Kricker JA; Gudjonsson T; Page CP
    Adv Pharmacol; 2023; 98():83-110. PubMed ID: 37524493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged treatment with macrolides in adult patients with non-cystic fibrosis bronchiectasis: meta-analysis of randomized controlled trials.
    Zhuo GY; He Q; Xiang-Lian L; Ya-Nan Y; Si-Te F
    Pulm Pharmacol Ther; 2014 Oct; 29(1):80-8. PubMed ID: 24594263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term macrolide maintenance therapy in non-CF bronchiectasis: evidence and questions.
    Haworth CS; Bilton D; Elborn JS
    Respir Med; 2014 Oct; 108(10):1397-408. PubMed ID: 25301290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term macrolide treatment for chronic respiratory disease.
    Spagnolo P; Fabbri LM; Bush A
    Eur Respir J; 2013 Jul; 42(1):239-51. PubMed ID: 23180583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preventing COPD exacerbations with macrolides: a review and budget impact analysis.
    Simoens S; Laekeman G; Decramer M
    Respir Med; 2013 May; 107(5):637-48. PubMed ID: 23352223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for macrolides in severe asthma?
    Brusselle GG; Joos G
    Curr Opin Pulm Med; 2014 Jan; 20(1):95-102. PubMed ID: 24247040
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New life for macrolides.
    Solidoro P; Braido F; Boffini M; Corsico AG
    Minerva Med; 2013 Dec; 104(6 Suppl 1):7-14. PubMed ID: 24327002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of atypical infections and macrolide therapy in patients with asthma.
    Rollins DR; Good JT; Martin RJ
    J Allergy Clin Immunol Pract; 2014; 2(5):511-7. PubMed ID: 25213043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.